Theravance Biopharma Inc.

Theravance Biopharma Inc. annual/quarterly net income history and growth rate from 2012 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.

• Theravance Biopharma Inc. net income for the quarter ending March 31, 2026 was -4.9 M, a 63.67% decrease year-over-year.
• Theravance Biopharma Inc. net income for the twelve months ending March 31, 2026 was 39.9 M, a 180.13% decrease year-over-year.
• Theravance Biopharma Inc. annual net income for 2025 was 105.9 M, a 287.70% decrease from 2024.
• Theravance Biopharma Inc. annual net income for 2024 was -56.4 M, a 2.22% increase from 2023.
• Theravance Biopharma Inc. annual net income for 2023 was -55.2 M, a 106.33% decrease from 2022.
• Theravance Biopharma Inc. annual net income for 2022 was 872.1 M.